Home › Research › Topics › samp8
samp8
5 studies tagged samp8, dated 2001-01-01 to 2016-10-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease 2016-10-01
- Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study 2013-06-15
- Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain 2012-01-01
Studies
5 studies carry this tag.
Date range
2001 to 2016
Top journals
- Journal of Alzheimer's disease : JAD 2
- Biochemistry and cell biology = Biochimie et biologie cellulaire 1
- Experimental neurology 1
- Free radical biology & medicine 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Glycogen synthase kinase (GSK)-3β is a multifunctional protein that has been implicated in the pathological characteristics of Alzheimer's disease (AD), including the heightened levels of neurofibrillary tangles, amyloid-beta (Aβ), and neurodegeneration.
-
Amyloid β-peptide (Aβ) plays a central role in the pathophysiology of Alzheimer's disease (AD) through the induction of oxidative stress.
-
The senescence accelerated mouse-prone 8 (SAMP8) mouse model of Alzheimer's disease has a natural mutation leading to age-related increases in the amyloid-β protein precursor (AβPP) and amyloid-β (Aβ) in the brain, memory impairment, and deficits in Aβ removal from the brain.
-
Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.
-
Alzheimer's disease (AD) is associated with increased expression of amyloid precursor protein (APP) with a consequent deposition of amyloid beta peptide (Abeta) which forms characteristic senile plaques.